Novozymes A/S (NVZMF)

USD 57.0

(0.0%)

Annual Balance Sheets

(In DKK)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 28.39 Billion 27.98 Billion 24.76 Billion 20.51 Billion 20.43 Billion 19.69 Billion
Total Current Assets 9.46 Billion 9.24 Billion 7.82 Billion 6.91 Billion 7.05 Billion 6.83 Billion
Cash And Short Term Investments 1.15 Billion 1.12 Billion 1.03 Billion 1.3 Billion 726 Million 737 Million
Cash and Cash Equivalents 1.11 Billion 1.04 Billion 963 Million 1.18 Billion 711 Million 723 Million
Short Term Investments 40 Million 80 Million 75 Million 119 Million 15 Million 14 Million
Net Receivables 3.77 Billion 4.14 Billion 3.79 Billion 3.22 Billion 3.64 Billion 3.27 Billion
Inventory 3.62 Billion 3.8 Billion 2.99 Billion 2.36 Billion 2.61 Billion 2.82 Billion
Other Current Assets 947 Million 174 Million 880 Million 23 Million 62 Million 407 Million
Total Non-Current Assets 18.92 Billion 18.74 Billion 16.94 Billion 13.59 Billion 13.38 Billion 12.86 Billion
Net PPE 12.32 Billion 12.07 Billion 10.18 Billion 9.61 Billion 10.21 Billion 9.69 Billion
Good Will And Intangible Assets 4.53 Billion 4.69 Billion 5.02 Billion 2.55 Billion 1.92 Billion 2.13 Billion
Good Will 1.97 Billion 2 Billion 2.02 Billion 1.09 Billion 965 Million 1.08 Billion
Intangible Assets 2.55 Billion 2.69 Billion 3 Billion 1.45 Billion 961 Million 1.04 Billion
Long-Term Investments 227 Million 235 Million -16 Million -65 Million 44 Million 48 Million
Tax Assets 1.76 Billion 1.62 Billion 1.63 Billion 1.33 Billion 1.16 Billion 938 Million
Other Non Current Assets 83 Million 112 Million 114 Million 159 Million 44 Million 48 Million
Other Assets - - - - - -
Total Liabilities 14.04 Billion 13.75 Billion 12.56 Billion 9.26 Billion 8.95 Billion 8.25 Billion
Total Current Liabilities 7.26 Billion 6.96 Billion 5.67 Billion 4.16 Billion 4.73 Billion 5.52 Billion
Account Payables 1.61 Billion 1.86 Billion 1.49 Billion 1.1 Billion 1.11 Billion 1.41 Billion
Tax Payables 183 Million 326 Million 486 Million 336 Million 431 Million 575 Million
Short Term Debt 137 Million 123 Million 122 Million 136 Million 1.54 Billion 1.78 Billion
Deferred Revenue 4.85 Billion 138 Million 163 Million 89 Million 664 Million 188 Million
Other Current Liabilities 656 Million 4.83 Billion 3.89 Billion 2.83 Billion 1.41 Billion 2.13 Billion
Total Non Current Liabilities 6.77 Billion 6.79 Billion 6.88 Billion 5.1 Billion 4.22 Billion 2.73 Billion
Long-Term Debt 232 Million 288 Million 360 Million 3.64 Billion 3.15 Billion 1.46 Billion
Deferred Revenue Non Current 152 Million 129 Million 98 Million 115 Million - 236 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 4.42 Billion 4.72 Billion 5.09 Billion 146 Million 184 Million 137 Million
Other Liabilities - - - - - -
Total Equity 14.35 Billion 14.22 Billion 12.2 Billion 11.24 Billion 11.48 Billion 11.43 Billion
Stock Holders Equity 13.97 Billion 13.83 Billion 11.82 Billion 11.23 Billion 11.46 Billion 11.42 Billion
Common Stock 562 Million 562 Million 564 Million 570 Million 582 Million 594 Million
Retained Earnings 13.75 Billion 13.06 Billion 11.3 Billion 11.26 Billion 10.81 Billion 10.94 Billion
Accumulated other comprehensive income -339 Million 213 Million -40 Million -600 Million 76 Million -112 Million
Common Stock Equity 13.97 Billion 13.83 Billion 11.82 Billion 11.23 Billion 11.46 Billion 11.42 Billion
Capital Lease Obligation 369 Million 411 Million 482 Million 522 Million 616 Million -
Total Investments 267 Million 315 Million 59 Million 54 Million 59 Million 62 Million
Total Debt 369 Million 411 Million 482 Million 3.77 Billion 4.7 Billion 3.25 Billion
Net Debt -747 Million -630 Million -481 Million 2.59 Billion 3.99 Billion 2.53 Billion

Balance Sheet Charts